Abstract |
Fibrinogen radioiodinated by the iodine monochloride method was tested as a tumour radiodiagnostic agent in mice. The I- fibrinogen cleared from the blood of tumour-bearing mice more rapidly than from that of normal mice, but it cleared from the whole body more slowly, suggesting it accumulated in a substantial tumour-related compartment in the abnormal mice. The tumour concentration steadily increased for 4 h after injection, at which time it reached a peak concentration of 11-4% of the injected dose/g. This concentration was higher than the peak concentration for Ga- citrate (not reached until 24 h) or any other oncophilic radiopharmaceutical tested in this tumour model. The early accumulation is consistent with the use of 123I as a tracer label for fibrinogen. A combination of the large tumour concentration of I- fibrinogen, an increased catabolic rate induced by chemical modification, and the exceptional nuclear properties of 123I for scintigraphic imaging, could lead to a very useful radiodiagnostic procedure for cancer.
|
Authors | K A Krohn, S J DeNardo, D W Wheeler, G L DeNardo |
Journal | British journal of cancer
(Br J Cancer)
Vol. 36
Issue 2
Pg. 227-34
(Aug 1977)
ISSN: 0007-0920 [Print] England |
PMID | 911661
(Publication Type: Journal Article)
|
Chemical References |
- Iodine Radioisotopes
- Fibrinogen
|
Topics |
- Adenocarcinoma
(diagnosis, metabolism)
- Animals
- Electrophoresis, Polyacrylamide Gel
- Fibrinogen
(metabolism)
- Iodine Radioisotopes
- Kinetics
- Mice
- Mice, Inbred BALB C
- Neoplasms, Experimental
(metabolism)
|